MarketPulse
L

$LH

5 articles found
4 positive
0 negative
1 neutral
BenzingaBenzinga··Vandana Singh

Labcorp Surges on Strong Q1 Beat, AI Investments Drive 2026 Guidance Hike

Labcorp ($LH) shares rise 1.46% after beating Q1 earnings expectations with $4.25 adjusted EPS and raising full-year 2026 guidance, bolstered by AI and robotics investments.
LHAI investmentsstock performance
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Drug Development Services Market Set to Double to $50B by 2030

Drug development services market projected to reach $50.26B by 2030 from $28.09B in 2025, driven by AI adoption, personalized medicine, and emerging market expansion.
CRLIQVLZAGYLHWUXAYregulatory complianceclinical trials
BenzingaBenzinga··Prnewswire

Labcorp Declares $0.72 Quarterly Dividend, Signaling Confidence in Cash Flow

Labcorp ($LH) declared a $0.72 quarterly dividend payable June 11, 2026, reflecting confidence in cash generation from its dominant diagnostic testing market position.
LHdividendcash dividend
GlobeNewswire Inc.GlobeNewswire Inc.··Mordor Intelligence

Drug Screening Market Set to Double to $20.86B by 2031 Amid Tech Boom

Global drug screening market projects 16.16% CAGR growth through 2031. Chromatography and mass spectrometry lead with 44.77% share; Asia-Pacific fastest growing.
ABTTMODHRSMMNYBIO+4Asia Pacific growthpoint-of-care testing
GlobeNewswire Inc.GlobeNewswire Inc.··Sns Insider

Genomics Services Market Set to Triple to $25.18B by 2035 as Genetic Disorders Surge

Global genomics services market projected to grow from $7.94B in 2025 to $25.18B by 2035, driven by rising genetic disorder prevalence and precision medicine initiatives.
ILMNTMOLHDGXprecision medicinecompanion diagnostics